Riskpilot← Back to searchSign inGet full accessiRAD Molecular Imaging Oy
OYActiveY-tunnus 2446672-9Sirkkalankatu 6-B19Medical specialists activities · NACE 8622Est. 2011— employeeswww.molecular.fi
Revenue 2025
EUR 194K
-7% vs 2024
EBITDA margin
7.3%
-26% vs 2024
Equity ratio
92.0%
Financial strength
Net profit 2025
EUR 11K
-21% vs 2024
| Revenue | EUR 194K | -7% |
| EBITDA | EUR 14K | -26% |
| Net profit | EUR 11K | -21% |
| Total assets | EUR 169K | +0% |
| Equity | EUR 155K | -1% |
| Employees | — | — |
Legal name
iRAD Molecular Imaging Oy
Y-tunnus number
2446672-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
7. joulukuuta 2011
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimiala on lääkinnällisten palveluiden tuottaminen, teleradiologiset palvelut, johon sisältyy tutkimusten suunnittelu, kuvantamistutkimusten analysointi ja alan konsultointi. Lisäksi yhtiön toimialaan kuuluvat muut lääketieteelliset konsultaatiot sekä kliiniset auditointipalvelut.
Address
Sirkkalankatu 6-B19
Phone
+358400297859
Email
linda.paajarvi@molecular.fi
Website
www.molecular.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 232 | 343 | 369 | 209 | 194 |
| Staff expenses | −73 | −92 | −71 | −62 | −54 |
| EBITDA | 16 | 64 | 84 | 19 | 14 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 16 | 64 | 84 | 19 | 14 |
| Net financials | −0 | −0 | −0 | −1 | −0 |
| Profit before tax | 16 | 64 | 83 | 18 | 14 |
| Tax | 3 | 13 | 17 | 4 | 3 |
| Net profit | 13 | 51 | 67 | 14 | 11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 151 | 207 | 267 | 169 | 169 |
| Equity | 111 | 154 | 209 | 156 | 155 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 40 | 52 | 58 | 13 | 14 |
| Total debt | 40 | 52 | 58 | 13 | 14 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20212025
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
20212025
Return on equity
7.2%
This company
18.4%
Market median
-61% vs market
20212025
Net profit margin
5.8%
This company
8.1%
Market median
-28% vs market
20212025
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
FS Deputy auditor | Deputy auditor | 2026 |
LM Chief Executive Officer | Chief Executive Officer | 2024 |
EK | Audit | 2026 |
| Former (2) | ||
JK Chief Executive Officer | Chief Executive Officer | 2019 – 2021 |
JT Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
| Board of Directors | 2012 | |
| Chairperson | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of iRAD Molecular Imaging Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Sebastian Salonen | Deputy auditor | 0 companies |
| Linda Maria Pääjärvi | Chief Executive Officer | 0 companies |
| Elina Katariina Niemi | Audit | 0 companies |
| Julia Katariina Koskinen | Chief Executive Officer | 0 companies |
| Jarno Tapani Huhtanen | Chief Executive Officer | 0 companies |
| Matti Juhani Knuuti | Board of Directors | 0 companies |
| Sami Antero Kajander | Board of Directors | 0 companies |
| Heikki Ralph Ilmari Minn | Board of Directors | 0 companies |
| Marko Petteri Seppänen | Board of Directors | 0 companies |
| Jukka Tapani Kemppainen | Chairperson | 0 companies |